Mouat, Margaret A. and Coleman, James L. J. and Wu, Jianxin and dos Remedios, Cristobal G. and Feneley, Michael P. and Graham, Robert M. and Smith, Nicola J. (2021) Involvement of GPR37L1 in murine blood pressure regulation and human cardiac disease pathophysiology. American Journal of Physiology-Heart and Circulatory Physiology, 321 (4). pp. H807-H817. ISSN 0363-6135
Full text not available from this repository.Abstract
Multiple mouse lines lacking the orphan G protein-coupled receptor, GPR37L1, have elicited disparate cardiovascular phenotypes. The first Gpr37l1 knockout mice study to be published reported a marked elevation in systolic blood pressure (SBP; approximately 60 mmHg), revealing a potential therapeutic opportunity. The phenotype differed from our own independently generated knockout line, where male mice exhibited equivalent baseline blood pressure to wild type. Here, we attempted to reproduce the first study by characterizing the cardiovascular phenotype of both the original knockout and transgenic lines alongside a C57BL/6J control line, using the same method of blood pressure measurement. The present study supports the findings from our independently developed Gpr37l1 knockout line, finding that SBP and diastolic blood pressure (DBP) are not different in the original Gpr37l1 knockout male mice (SBP: 130.9 +/- 5.3 mmHg; DBP: 90.7 +/- 3.0 mmHg) compared with C57BL/6J mice (SBP: 123.1 +/- 4.1 mmHg; DBP: 87.0 +/- 2.7 mmHg). Instead, we attribute the apparent hypertension of the knockout line originally described to comparison with a seemingly hypotensive transgenic line (SBP 103.7 +/- 5.0 mmHg; DBP 71.9 +/- 3.7 mmHg). Additionally, we quantified myocardial GPR37L1 transcript in humans, which was suggested to be downregulated in cardiovascular disease. We found that GPR37L1 has very low native transcript levels in human myocardium and that expression is not different in tissue samples from patients with heart failure compared with sex-matched healthy control tissue. These findings indicate that cardiac GPR37L1 expression is unlikely to contribute to the pathophysiology of human heart failure.NEW & NOTEWORTHY This study characterizes systolic blood pressure (SBP) in a Gpr37l1 knockout mouse line, which was previously reported to have approximately 60 mmHg higher SBP compared with a transgenic line. We observed only a approximately 27 mmHg SBP difference between the lines. However, when compared with C57BL/6J mice, knockout mice showed no difference in SBP. We also investigated GPR37L1 mRNA abundance in human hearts and observed no difference between healthy and failing heart samples.
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Depositing User: | Repository Administrator |
| Date Deposited: | 10 Dec 2021 04:03 |
| Last Modified: | 10 Dec 2021 04:03 |
| URI: | http://eprints.victorchang.edu.au/id/eprint/1178 |
Actions (login required)
 |
View Item |